Catherine J. Huntoon

Author

Mayo Clinic

Also Known As

C Huntoon, C J Huntoon, C. Huntoon, Catherine Huntoon, Catherine J Huntoon, Catherine J. Huntoon

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona WinnMed National Institutes of Health National Cancer Institute

About

Catherine J. Huntoon is an author at Mayo Clinic specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	586
2	Cell Biology	11	11	586
3	Natural Sciences	2	2	56
4	Allergy	2	2	45
5	Health Sciences	1	1	46

Catherine J. Huntoon

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Interleukin-1-stimulated NF-κB RelA/p65 Phosphorylation by Mesalamine Is Accompanied by Decreased Transcriptional Activity Laurence J. Egan, Dennis C. Mays, Catherine J. Huntoon, Journal of Biological Chemistry	1999	212
ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status Catherine J. Huntoon, Karen S. Flatten, Andrea E. Wahner Hendrickson, Cancer Research Chemotherapy IndependentOncologyCell RegulationOncogenic AgentMedicine	2013	207
Ovarian Cancer-associated Mutations Disable Catalytic Activity of CDK12, a Kinase That Promotes Homologous Recombination Repair and Resistance to Cisplatin and Poly(ADP-ribose) Polymerase Inhibitors Poorval Joshi, Shari L. Sutor, Catherine J. Huntoon, Journal of Biological Chemistry	2014	201
RAD18-mediated ubiquitination of PCNA activates the Fanconi anemia DNA repair network Liyi Geng, Catherine J. Huntoon, Larry M. Karnitz The Journal of Cell Biology	2010	101
Ly9 (CD229)-Deficient Mice Exhibit T Cell Defects yet Do Not Share Several Phenotypic Characteristics Associated with SLAM- and SAP-Deficient Mice Daniel B. Graham, Michael P. Bell, Megan McCausland, The Journal of Immunology	2006	87
Heat Shock Protein 90 Inhibition Depletes LATS1 and LATS2, Two Regulators of the Mammalian Hippo Tumor Suppressor Pathway Catherine J. Huntoon, Monica D. Nye, Liyi Geng, Cancer Research Ctgf GeneSignal TransductionSignaling PathwayHsp90 InhibitorsChemoprevention Strategy	2010	71
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer Dongqing Huang, Shrabanti Chowdhury, Hong Wang, Cell Reports Medicine	2021	71
BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents Arun Kanakkanthara, Kiran Kurmi, Thomas L. Ekstrom, Cancer Research	2019	68
Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element Karen E. Hedin, M P Bell, Kimberly R. Kalli, The Journal of Immunology	1997	65
Mechanism Responsible for T-Cell Antigen Receptor- and CD28- or Interleukin 1 (IL-1) Receptor-Initiated Regulation of IL-2 Gene Expression by NF-κB Kimberly R. Kalli, Catherine J. Huntoon, Michael V. Bell, Molecular and Cellular Biology T-regulatory CellImmune RegulationImmunologyIkappabalpha DegradationImmunologic Mechanism	1998	62

Page 1